Lawaetz Martin, Serup Julie, Lawaetz Birgit, Bjoern Lars, Blemings Allan, Eklof Bo, Rasmussen Lars
The Danish Vein Centers and Surgical Center Roskilde, Naestved, Denmark -
The Danish Vein Centers and Surgical Center Roskilde, Naestved, Denmark.
Int Angiol. 2017 Jun;36(3):281-288. doi: 10.23736/S0392-9590.17.03827-5. Epub 2017 Feb 17.
This study compares the outcome 5 years after treatment of varicose veins with endovenous radiofrequency ablation (RFA), endovenous laser ablation (EVLA), ultrasound guided foam sclerotherapy (UGFS) or high ligation and stripping (HL/S) by assessing technical efficacy, clinical recurrence and the rate of reoperations.
Five hundred patients (580 legs) with Great Saphenous Vein (GSV) reflux and varicose veins were randomized to one of the 4 treatments. Follow-up included clinical and duplex ultrasound examinations.
During 5 years there was a difference in the rate of GSV recanalization, recurrence and reoperations across the groups, KM P<0.001, P<0.01, P<0.001 respectively. Thus 8 in the RFA group (Kaplan Meier [KM] estimate 5.8%), 8 in the EVLA group (KM estimate 6.8%), 37 (KM estimate 31.5%) in the UGFS group and 8 in the HL/S group (KM estimate 6.3%) of GSVs recanalized or had a failed stripping procedure. Nineteen (RFA) (KM estimate 18.7%), 42 (EVLA) (KM estimate 38.6%), 28 (UGFS) (KM estimate 31.7%) and 38 (HL/S) (KM estimate 34.6%) legs developed recurrent varicose veins. Within 5 years after treatment, 19 (RFA) (KM estimate 17%), 19 (EVLA) (KM estimate 18.7%), 43 (UGFS) (KM estimate 37.7%) and 25 (HL/S) (KM estimate 23.4%) legs were retreated.
More recanalization's of the GSV occurred after UGFS and no difference in the technical efficacy was found between the other modalities during 5-year follow-up. The higher frequency of clinical recurrence after EVLA and HL/S cannot be explained and requires confirmation in other studies.
本研究通过评估技术疗效、临床复发率和再次手术率,比较了大隐静脉射频消融术(RFA)、大隐静脉激光消融术(EVLA)、超声引导下泡沫硬化疗法(UGFS)或高位结扎剥脱术(HL/S)治疗静脉曲张5年后的疗效。
500例(580条腿)患有大隐静脉(GSV)反流和静脉曲张的患者被随机分配至4种治疗方法之一。随访包括临床检查和双功超声检查。
在5年期间,各组之间的GSV再通率、复发率和再次手术率存在差异,分别为KM P<0.001、P<0.01、P<0.001。因此,RFA组有8例(Kaplan Meier [KM]估计值为5.8%),EVLA组有8例(KM估计值为6.8%),UGFS组有37例(KM估计值为31.5%),HL/S组有8例(KM估计值为6.3%)的GSV发生再通或剥脱手术失败。19例(RFA)(KM估计值为18.7%)、42例(EVLA)(KM估计值为38.6%)、28例(UGFS)(KM估计值为31.7%)和38例(HL/S)(KM估计值为34.6%)的腿出现了复发性静脉曲张。治疗后5年内,19例(RFA)(KM估计值为17%)、19例(EVLA)(KM估计值为18.7%)、43例(UGFS)(KM估计值为37.7%)和25例(HL/S)(KM估计值为23.4%)的腿接受了再次治疗。
UGFS术后GSV再通更多,在5年随访期间,其他治疗方式在技术疗效上未发现差异。EVLA和HL/S术后临床复发频率较高,原因不明,需要其他研究予以证实。